abstract |
The present invention provides transgenic non-human animals, particularly transgenic mice encoding Qpct protein associated with Qpct-related diseases. In addition, the present invention provides cells and cell lines that contain a transgene encoding for Qpct. The present invention further provides methods and compositions for evaluating agents that affect Qpct for use in compositions for the treatment of Qpct-related diseases. [Selection figure] None |